Immediate antiretroviral therapy in young HIV-infected children: benefits and risks
- PMID: 24247666
- PMCID: PMC3868023
- DOI: 10.1097/COH.0000000000000027
Immediate antiretroviral therapy in young HIV-infected children: benefits and risks
Abstract
Purpose of review: Recent WHO guidelines recommend immediate initiation of lifelong antiretroviral therapy (ART) in all children below 5 years, irrespective of immune/clinical status, to improve access to paediatric ART. Interim trial results provide strong evidence for immediate ART during infancy because of high short-term risk of mortality and disease progression, but there is wider debate regarding the potential risks and benefits of immediate ART in asymptomatic children aged above 1 year. Concerns include long-term toxicities and treatment failure, particularly in resource-constrained settings with limited paediatric treatment options.
Recent findings: Benefits of immediate ART among infants appear to be maintained in the mid-term to long-term, with low risk of treatment failure, and better neurodevelopmental outcomes. In contrast, a trial reported no benefits of immediate versus deferred ART in asymptomatic children aged above 1 year. However, observational studies suggest that ART initiation at older ages and lower CD4 reduces the probability of immune reconstitution, with unclear implications on risk of clinical events or treatment change. A recent trial on treatment interruption following early intensive ART suggest that this may be a safe alternative approach.
Summary: Although there are clear benefits of immediate ART among infants, there remains conflicting evidence on the benefits for older children.
Similar articles
-
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial.Lancet. 2013 Nov 9;382(9904):1555-63. doi: 10.1016/S0140-6736(13)61409-9. Lancet. 2013. PMID: 24209829 Free PMC article. Clinical Trial.
-
Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.PLoS Med. 2013 Oct;10(10):e1001542. doi: 10.1371/journal.pmed.1001542. Epub 2013 Oct 29. PLoS Med. 2013. PMID: 24204216 Free PMC article.
-
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.Trials. 2013 Jul 23;14:230. doi: 10.1186/1745-6215-14-230. Trials. 2013. PMID: 23880306 Free PMC article. Clinical Trial.
-
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question.AIDS Res Ther. 2016 Jul 26;13:27. doi: 10.1186/s12981-016-0111-1. eCollection 2016. AIDS Res Ther. 2016. PMID: 27462361 Free PMC article. Review.
-
Screening for HIV Infection in Asymptomatic, Nonpregnant Adolescents and Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2019 Jun 18;321(23):2337-2348. doi: 10.1001/jama.2019.2592. JAMA. 2019. PMID: 31184705
Cited by
-
Early treatment regimens achieve sustained virologic remission in infant macaques infected with SIV at birth.Nat Commun. 2022 Aug 16;13(1):4823. doi: 10.1038/s41467-022-32554-z. Nat Commun. 2022. PMID: 35973985 Free PMC article.
-
Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor head trauma.Metab Brain Dis. 2018 Apr;33(2):537-544. doi: 10.1007/s11011-018-0196-4. Epub 2018 Feb 9. Metab Brain Dis. 2018. PMID: 29427049
-
Neurodevelopment at 11 months after starting antiretroviral therapy within 3 weeks of life.South Afr J HIV Med. 2019 Oct 30;20(1):1008. doi: 10.4102/sajhivmed.v20i1.1008. eCollection 2019. South Afr J HIV Med. 2019. PMID: 31745434 Free PMC article.
-
Diffusion tensor imaging point to ongoing functional impairment in HIV-infected children at age 5, undetectable using standard neurodevelopmental assessments.AIDS Res Ther. 2020 May 19;17(1):20. doi: 10.1186/s12981-020-00278-z. AIDS Res Ther. 2020. PMID: 32430069 Free PMC article.
-
Considerable variation in the 95-95-95 targets accomplishment between children and adults might delay achievement of set targets.Front Public Health. 2025 Apr 29;13:1565242. doi: 10.3389/fpubh.2025.1565242. eCollection 2025. Front Public Health. 2025. PMID: 40365438 Free PMC article. Review.
References
-
- UNAIDS: a progress report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive; 2012. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspubl... [Accessed 26 February 2013]
-
- World Health Organization/UNICEF/UNAIDS WH: Global Update on HIV Treatment 2013: Results, Impact and Opportunities. 2013. http://apps.who.int/iris/bitstream/10665/85326/1/9789241505734_eng.pdf [Accessed 14 February 2013]
-
- UNAIDS: 2013 Progress Report on the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. 2013. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspubl... [Accessed 15 September 2013]
-
- Newell M-L, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236–1243 - PubMed
-
- Becquet R, Marston M, Dabis F, et al. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PLoS One 2012; 7:e28510. - PMC - PubMed
-
A large pooled analysis of over 12 000 children, which showed poorer survival in perinatally infected as compared to postnatally infected children without ART.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials